Swiss drug maker Novartis projected that revenue would continue to grow despite upcoming drug patent expirations. The company pointed to efficiencies in research and development driven by artificial intelligence, as well as new candidates in its drug pipeline.
Health-Care Stocks Fall as Investors Leave Insurers
Health-care shares declined as traders continued to pull back from health insurers amid regulatory concerns. UnitedHealth Group fell more than 3% in the session, leaving its stock roughly 23% below its July highs.
When reusing this material a link to Money Talk is required.





Comments (0)
No comments yet. Be the first!